Smurfit Kappa GP — Director's Dealing 2018

May 21, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7270O

Credit Suisse Securities (Eur) Ltd

21 May 2018

Ap27

FORM 38.5(b)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY 

STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

1.          KEY INFORMATION

Name of exempt principal trader	Credit Suisse Securities (Europe) Ltd
Company dealt in	Smurfit Kappa Group Plc
Class of relevant security to which the dealings being disclosed relate (Note 1)	Ordinary
Date of dealing	18 May 2018

2.          INTERESTS AND SHORT POSITIONS

(a)         Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

	Long			Short
	Number		(%)	Number		(%)
(1) Relevant securities	1			0
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total	1			0

(b)         Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

Class of relevant security:	Long			Short
	Number		(%)	Number		(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap28

3.       DEALINGS (Note 3)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (EUR / GBp)
S	30	649.59
S	151	34.94
S	350	34.86
S	122	34.78
S	371	34.76
S	521	34.74
S	1	34.72
S	484	34.70
S	542	34.68
S	146	34.66
B	333	34.57
S	222	34.57
B	17588	34.52
S	12420	34.52
B	4399	34.51
S	4399	34.51
S	416	34.50
S	368	34.48
S	289	34.38
S	16	34.26
S	18	34.24
S	423	34.22
S	488	34.16
S	4	34.14
S	573	34.10
S	17	34.00
S	12	33.86
B	536	33.83
S	402	33.83
B	904	33.80
S	928	33.80
S	77	33.78
S	15	3,032.00
S	254	3,030.00
S	24	3,010.00
S	245	3,006.00
B	3386	2,993.24
S	1693	2,993.24
B	295	2,988.00
S	295	2,988.00
S	446	2,986.00
S	550	2,980.00
S	159	2,978.00
B	916	2,969.88
S	916	2,969.88
B	916	2,969.63
S	916	2,969.63
B	280	2,962.00
S	280	2,962.00
B	341	2,960.00
S	341	2,960.00

(b)      Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 5)	Number of relevant securities (Note 6)	Price per unit (Note 4)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 4)

(ii)      Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 4)

(d)      Other dealings (including transactions in respect of new securities) (Note 3)

Nature of transaction (Note 7)	Details	Price per unit (if applicable) (Note 4)

Ap29

4.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities 

under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. 

If none, this should be stated.

Is a Supplemental Form 38.5(b) attached? (Note 8)                    NO

Date of disclosure	21-May-2018
Contact name	Anthony Allen / Paul MacDonald
Telephone number	0207 888 5416 / 8548
Name of offeree/offeror with which connected	Smurfit Kappa Group Plc
Nature of connection (Note 9)	Corporate Broker to Offeree

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ISEBGGDUDBDBGIB